Development of the Smoking Cessation quality of life questionnaire

Olufade, Abayomi O.; Shaw, James W.; Foster, Stephan L.; Leischow, Scott J.; Coons, Stephen Joel

doi:10.1016/s0149-2918(00)87242-2

Cited by 48 publications

(39 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…(5,14,(16)(17)(18) In our study, only subjects who self-reported cessation and presented low exhaled CO levels (confirmed abstinence) were classified as quitters.…”

Section: Discussionmentioning

confidence: 96%

The impact of smoking cessation on patient quality of life

et al. 2009

View full text Add to dashboard Cite

Objective: To evaluate changes in health-related quality of life (HRQoL) after twelve months of smoking cessation. Methods: This was a prospective study to evaluate the effectiveness of a smoking cessation program on the quality of life of 60 self-referred subjects, at a public hospital, during the period of August 2006 to December 2007. The program consisted of 2-h group sessions once a week during the first month and then every 15 days over six months, followed by monthly phone contacts for another six months. The treatment was based on behavior modification and the use of bupropion in combination with nicotinic replacement therapy. Abstinence was verified by exhaled CO measurements. Patient HRQoL was quantified using the Medical Outcomes Study 36-item ShortForm Health Survey (SF-36) questionnaire. Differences in quality of life scores between quitters and non-quitters at twelve months after the initial intervention were evaluated using analysis of covariance with baseline characteristics as covariates. Results: Self-reported quality of life scores were significantly higher among the 40 quitters than among the 20 non-quitters. The following SF-36 domains were most affected: role-emotional (p = 0.008); general health (p = 0.006); vitality (p < 0.001); and mental health (p = 0.002). At twelve months after the smoking cessation intervention, the SF-36 mental component and physical component summary scores were higher among quitters than among non-quitters (p = 0.004 and p = 0.001, respectively). Conclusions: Our findings illustrate that smoking abstinence is related to better HRQoL, especially in aspects of mental health.Keywords: Quality of life; Smoking cessation; Questionnaires. ResumoObjetivo: Avaliar alterações na qualidade de vida relacionada à saúde (QVRS) doze meses após a cessação tabágica. Métodos: Estudo prospectivo para avaliar a efetividade de um programa de tratamento de fumantes, em relação à qualidade de vida, com 60 pacientes atendidos em um hospital público no período de agosto de 2006 a dezembro de 2007. O programa consistiu de sessões em grupo semanais com 2 h de duração durante o primeiro mês e quinzenais até o sexto mês, seguidas por telefonema mensal durante mais seis meses. O tratamento foi baseado na mudança comportamental e no uso de bupropiona associada à terapia de reposição nicotínica. A abstinência foi aferida pela medida de CO exalado. A QVRS dos pacientes foi quantificada através do questionário Medical Outcomes Study 36-item Short-Form Health Survey . Diferenças nos escores de qualidade de vida entre ex-fumantes e fumantes ativos doze meses após a intervenção inicial foram analisadas utilizando-se a análise de covariância com as características basais como covariáveis. Resultados: Os escores de qualidade de vida autorrelatados foram significativamente maiores nos 40 ex-fumantes do que nos 20 fumantes ativos. Os seguintes domínios do SF-36 foram mais afetados: papel emocional (p = 0,008); saúde geral (p = 0,006); vitalidade (p < 0,001) e saúde mental (p = 0,002). Doze meses...

show abstract

“…(5,14,(16)(17)(18) In our study, only subjects who self-reported cessation and presented low exhaled CO levels (confirmed abstinence) were classified as quitters.…”

Section: Discussionmentioning

confidence: 96%

The impact of smoking cessation on patient quality of life

et al. 2009

View full text Add to dashboard Cite

show abstract

“…Deve-se considerar que foram excluídos da amostra os sujeitos que referiam ter alguma patologia tabaco-relacionada ou problemas com outras substâncias psicoativas. Vários autores constataram menores escores nos componentes de outras escalas de avaliação da qualidade de vida, sendo a mais comumente utilizada a SF-36 (Mulder et al, 2001;Olufade et al, 1999;Wilson et al, 1999).…”

Section: Discussionunclassified

“…Essa medida pode ter um papel mais imediato na motivação desses indivíduos, uma vez que as patologias associadas ao tabaco, as quais, muitas vezes, levam o indivíduo a contemplar uma possibilidade de mudança do hábito de fumar, só costumam ocorrer após um longo tempo de exposição ao fumo (Olufade et al, 1999;Wilson et al, 1999).…”

Section: Tabagismounclassified

“…Nos últimos anos tem sido observado um aumento no número de pesquisas que mensuram a qualidade de vida em tabagistas e um ponto em comum encontrado nesses estudos foi a melhor qualidade de vida dos não-tabagistas quando comparados aos tabagistas (Olufade et al, 1999;Woolf et al, 1999;Wilson et al, 1999;Mitra et al, 2004). No entanto, deve-se observar que, em muitos desses trabalhos, os indivíduos não foram categorizados de acordo com a gravidade da dependência ou com o número de cigarros utilizados, bem como não foi dada atenção à presença de comorbidades psiquiátricas.…”

Section: Tabagismounclassified

See 1 more Smart Citation

Qualidade de vida e gravidade da dependência de tabaco

Castro¹,

Oliveira

Moraes³

et al. 2007

Rev. psiquiatr. clín.

View full text Add to dashboard Cite

ResumoContexto: A qualidade de vida é um constructo que vem ganhando importância como uma forma de acessar o impacto tanto de uma patologia quanto de uma estratégia terapêutica na vida dos sujeitos. Este parâmetro tem sido pesquisado nas mais variadas áreas, entre as quais o tabagismo. Objetivo: Avaliar a associação entre a qualidade de vida e a gravidade da dependência do tabaco. Método: Foi realizado um estudo transversal, com uma amostra por conveniência de 276 dependentes de tabaco da população geral, sem doenças tabaco-relacionadas. Os instrumentos utilizados foram: World Health Organization Quality of Life Instrument (WHOQOL-BREF), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Fagerström Test for Nicotine Dependence e ficha com dados sociodemográficos. Resultados: Foi verificada associação entre a gravidade da dependência de tabaco e piores escores em todos os domínios da qualidade de vida, avaliada por WHOQOL-BREF, tendo sido esse resultado influenciado por sintomas de ansiedade e depressão. Conclusão: Os tabagistas mais graves têm mais prejuízos na qualidade de vida, no entanto esse grupo é o que apresenta os escores mais elevados de sintomas depressivos e de ansiedade, sendo importante realizar mais estudos a esse respeito.Castro, M.G. et al. / Rev. Psiq. Clín. 34 (2); 61-67, 2007 Palavras-chave: Nicotina, qualidade de vida, tabaco. AbstractBackground: Quality of life is a construct that has been increasing its importance as a means to access the impact, either of a given pathology or of a therapeutic strategy applied to a given subject. This parameter has been researched in the most various areas, among which, smoking. Objective: Evaluating the association between quality of life and the severity of tobacco dependence. Method: A transversal study has been applied, using a convenience sample of 276 tobacco users, selected at random, tobacco-related diseases free. The instruments used were: World Health Organization Quality of Life Instrument (WHOQOL-BREF), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Fagerström Test for Nicotine Dependence and a social and demographic data file. Results: It has been found association between the severity of tobacco dependence and the lowest scores in all domains of quality of life, evaluated by WHOQOL-BREF. Such result has been influenced by anxiety and depression symptoms. Conclusion: Heavy smokers have less quality of life but this group its also that with heavy depressive and anxiety symptoms, therefore, it is important that more studies are applied on the topic.

show abstract

“…For example, physical and mental health composite scores for the SF-36 are available [31]. Disease specific supplements for the SF-36 have been developed for angina pectoris [22], liver disease [32], kidney disease [33], epilepsy [34], multiple sclerosis [35], smoking cessation [36], prostate cancer [37], and duodenal ulcer patients [38].…”

mentioning

confidence: 99%

The relevance of health related quality of life in paced patients

Stofmeel

Stel

Hemel

et al. 2005

International Journal of Cardiology

View full text Add to dashboard Cite

With the tremendous advances in cardiac pacing during the past four decades, cardiac pacemaker implantation is now a common clinical procedure. In recent years, the indications for permanent pacemakers have expanded. This increase in reasons for pacing and shift in mode of pacing have been caused by the evolution of pacemaker therapy from a life-saving measure (mortality), to one aimed at improving healthrelated quality of life (HRQoL). Until now the efficacy of pacing therapy has predominantly been measured using bobjectiveQ criteria. However, in recent years the importance of HRQoL as an outcome measure has increasingly been recognized as patients prefer quality over quantity of life.In this review we describe the development and testing of Aquarel, a new developed HRQoL questionnaire for pacemaker patients, composed of a generic core module with disease specific add-ons. Current and future research to improve the Aquarel questionnaire is also described. D 2005 Elsevier Ireland Ltd. All rights reserved.Keywords: Cardiac pacing; Quality of life; Aquarel In the Netherlands there is an increased implantation rate of cardiac pacemakers in patients of all ages over the past decade (Fig. 1). This increase in the number of implanted pacemaker-units and leads combined with a rising population age contribute to an increase in hospitalisation, care and follow-up. Until now the efficacy of pacing therapy has predominantly been measured using clinical outcomes such as improvement of prognosis, relief of symptoms, complications, technical failures and recalls. However, to evaluate the full spectrum of outcome of pacemaker therapy patient reported outcomes as well as clinical outcomes should be measured. In recent years the importance of health-related quality of life (HRQoL) as an outcome measure has increasingly been recognized [1,2]. This has particular relevance in cardiac pacing because the goal of therapy for most patients with chronic disease is improvement in function, not cure [3]. These measures should be incorporated as one of the primary measures of outcome in the evaluation of new therapies in chronic diseases including cardiac pacing. Doing so, clinicians, patients, policymakers, health care providers and HRQoL researchers gain experience with these measures.To measure HRQoL, appropriate instruments should be used and a large number of questionnaires has been developed in the past two decades. However, in the field of cardiac pacing until recently several instruments were used to measure HRQoL that were not properly validated and applied [4][5][6][7][8][9][10][11][12][13][14][15][16][17]. Consequently these HRQoL data should be interpreted cautiously. HRQoL is typically measured either in a generic or a specific way. Generic means that an instrument gives information on several dimensions and is useful for a variety of illnesses, diseases and different (patient-) populations, allowing for comparison between these (patient-) populations. Disease specific questionnaires focus on dimensions most relevant ...

show abstract

Development of the Smoking Cessation quality of life questionnaire

Cited by 48 publications

References 36 publications

The impact of smoking cessation on patient quality of life

The impact of smoking cessation on patient quality of life

Qualidade de vida e gravidade da dependência de tabaco

The relevance of health related quality of life in paced patients

Contact Info

Product

Resources

About